A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.

Clinical trial NCT06487455 · RECRUITING

Trial details

NCT number: NCT06487455
Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-08-06
Primary completion: 2027-12-31
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.